Panamanian authorities have heightened health surveillance due to influenza A (H3N2) cases. After confirming three cases of the A (H3N2) subtype, the Ministry of Health (Minsa) decided to raise the epidemiological surveillance level, incorporating real-time PCR tests and genomic analysis to more rapidly detect respiratory viruses circulating in Panama. "Historically, influenza A (H1N1) has predominated, but in recent weeks we have started to see the presence of H3N2," detailed Dr. Blas Armien, head of national epidemiology. He emphasized that vaccination continues to save lives, especially for people with chronic illnesses, the elderly, young children, and pregnant women. This year, Panama acquired 1.2 million doses, administered through the Expanded Program on Immunization (PAI), achieving significant population coverage. Currently, vaccines are available in Panama Metro, San Miguelito, and Panama Norte, and are being administered without an appointment. Authorities reiterated the call for the population to reinforce prevention measures, avoid crowded places, and not self-medicate. Any symptoms must be evaluated at a health center.
